These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND PMS1, hPMS1, 5378, ENSG00000064933, PMSL1, HNPCC3, DKFZp781M0253 AND Treatment
7 results:

  • 1. Inguinal lymph node metastases from rectal adenocarcinoma: a systematic review.
    Wyatt J; Powell SG; Ahmed S; Arthur J; Altaf K; Ahmed S; Javed MA
    Tech Coloproctol; 2023 Nov; 27(11):969-978. PubMed ID: 37233960
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Molecular characterization of colorectal cancer using whole-exome sequencing in a Taiwanese population.
    Chang YS; Lee CC; Ke TW; Chang CM; Chao DS; Huang HY; Chang JG
    Cancer Med; 2019 Jul; 8(8):3738-3747. PubMed ID: 31127692
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Associations of Genetic Variations in Mismatch Repair Genes MSH3 and pms1 with Acute Adverse Events and Survival in Patients with Rectal cancer Receiving Postoperative Chemoradiotherapy.
    Yang J; Huang Y; Feng Y; Li H; Feng T; Chen J; Yin L; Wang W; Wang S; Liu Y; Song Y; Li Y; Jin J; Tan W; Lin D
    Cancer Res Treat; 2019 Jul; 51(3):1198-1206. PubMed ID: 30590005
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. DNA mismatch repair deficiency and hereditary syndromes in Latino patients with colorectal cancer.
    Ricker CN; Hanna DL; Peng C; Nguyen NT; Stern MC; Schmit SL; Idos GE; Patel R; Tsai S; Ramirez V; Lin S; Shamasunadara V; Barzi A; Lenz HJ; Figueiredo JC
    Cancer; 2017 Oct; 123(19):3732-3743. PubMed ID: 28640387
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Assessing pathogenicity of MLH1 variants by co-expression of human MLH1 and PMS2 genes in yeast.
    Vogelsang M; Comino A; Zupanec N; Hudler P; Komel R
    BMC Cancer; 2009 Oct; 9():382. PubMed ID: 19863800
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
    Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Hereditary and sporadic ovarian cancer: genetic testing and clinical implications (review).
    Angioli R; Estape R; Mason M; Penalver M
    Int J Oncol; 1998 May; 12(5):1029-34. PubMed ID: 9538124
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.